Product Pipeline

MAA Laboratories has created the NanoCont™ drug development platform as a broadly applicable solution for addressing a variety of drug delivery and development challenges. To this end, the NanoCont^TM platform combines customized drug delivery and controlled-release solutions with continuous manufacturing principles to drive the efficient development of patentable drug products with meaningful improvements in clinical performance.

In addition to providing innovative drug products through our unique development approaches to our pharmaceutical partners, MAA Laboratories is utilizing the NanoCont^TM technology to advance a number of innovative drug products. MAA’s pipeline of innovative medicines is specifically designed to provide meaningful clinical benefits to patients by addressing unmet clinical needs in a variety of therapeutic areas.

For inquiries related to product licensing and development partnerships, please contact our business development team at BD@maalaboratories.com.